Law360 ( April 3, 2008, 12:00 AM EDT) -- In yet another decision that will dramatically alter the landscape in the pharmaceutical industry, the Federal Circuit decided on Tuesday, in Caraco Pharm. Labs. Ltd. v. Forest Labs. Inc. (No. 2007-1404), that a generic drug applicant could bring a declaratory judgment action to challenge a brand company's patent even after the brand company granted a covenant not to sue....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.